Cargando…
Clusterin is a potential molecular predictor for ovarian cancer patient's survival: targeting Clusterin improves response to paclitaxel
BACKGROUND: Clusterin is a cytoprotective chaperone protein involved in numerous physiological processes, carcinogenesis, tumor growth and tissue remodelling. The purpose of this study was to investigate whether clusterin (CLU), an antiapoptotic molecule, could be a potential predictor molecule for...
Autores principales: | Hassan, Mohamed K, Watari, Hidemichi, Han, Yimin, Mitamura, Takashi, Hosaka, Masayoshi, Wang, Lei, Tanaka, Shinya, Sakuragi, Noriaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287343/ https://www.ncbi.nlm.nih.gov/pubmed/22185350 http://dx.doi.org/10.1186/1756-9966-30-113 |
Ejemplares similares
-
Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments
por: Mitamura, Takashi, et al.
Publicado: (2014) -
Multivariate survival analysis of the patients with recurrent endometrial cancer
por: Odagiri, Tetsuji, et al.
Publicado: (2011) -
P18/Stathmin1 is regulated by miR-31 in ovarian cancer in response to taxane
por: Hassan, Mohamed Kamel, et al.
Publicado: (2015) -
The role of Clusterin in cancer metastasis
por: Peng, Mei, et al.
Publicado: (2019) -
Clusterin Expression in Colorectal Carcinomas
por: Téllez, Teresa, et al.
Publicado: (2023)